In a meta-analysis deliberated beforehand, which studied COC use among BRCA1/2 mutation carriers, relationships between ever-use of oral contraceptives and ovarian and breast cancer among women who are carriers are akin to those shown for the common populace [50]. The gene discussed is BRCA1; the disease is breast cancer.